
Loading, please wait...

Loading, please wait...

Clinicians often encounter limited high-quality evidence regarding homeopathy for hemorrhoids, despite its widespread traditional use in various clinical settings. However, a recent double-blind, randomized, placebo-controlled trial offers new data on the efficacy of individualized homeopathic medicinal products (IHMPs). Researchers conducted this study at a tertiary homeopathic hospital in West Bengal, India, involving 134 adults diagnosed with grade I-III hemorrhoids.
During the three-month study period, participants received either IHMPs or an identical-looking placebo. Notably, both groups adhered to standard concomitant care, which included dietary modifications, sitz baths, and pelvic floor exercises. The primary analysis focused on the change in the Anorectal Symptom Severity and Quality-of-Life (ARSSQoL) total score. Consequently, the findings highlighted significant differences between the intervention and control groups.
After three months, the group receiving IHMPs demonstrated significantly greater improvement than the placebo group. Specifically, the mean group difference in the ARSSQoL total score was -6.5. Furthermore, secondary outcomes involving quality-of-life scales and numeric rating scales also favored the homeopathic treatment. Importantly, patients tolerated the individualized remedies well, and no serious adverse events occurred throughout the trial. Therefore, these results suggest that individualized homeopathy can serve as an effective adjunct to standard conservative management for symptomatic relief.
According to this randomized controlled trial, individualized homeopathic medicinal products significantly improved both symptom severity and quality-of-life scores compared to a placebo over a three-month period.
The study specifically included adults diagnosed with grade I, II, and III hemorrhoids. Those requiring immediate surgical intervention or suffering from grade IV disease were generally excluded from this specific primary care assessment.
The study reported that the treatment was safe and well-tolerated. No serious adverse events were documented, suggesting a high safety profile for individualized homeopathic management in the observed patient cohort.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Saha A et al. Treatment of Hemorrhoids with Individualized Homeopathic Medicinal Products: A Double-Blind, Randomized, Placebo-Controlled Trial. J Integr Complement Med. 2026 Apr 02. doi: 10.1177/27683605261435779. PMID: 41928045.
Central Council for Research in Homoeopathy. Clinical Research Guidelines in Homoeopathy. Ministry of AYUSH, Government of India.
Lohsiriwat V. Hemorrhoids: From basic pathophysiology to clinical management. World J Gastroenterol. 2012;18(17):2009-2017. doi: 10.3748/wjg.v18.i17.2009.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A randomized trial in India found that individualized homeopathic medicinal products significantly improved symptoms and quality of life in hemorrhoid patie...
5 months ago

A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today

Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Today

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today